Ting Deng Selected Research

diisononyl phthalate

1/2020	Exposure to diisononyl phthalate promotes atopic march by activating of NF-κB and p38 MAPK.
11/2018	Exposure to formaldehyde and diisononyl phthalate exacerbate neuroinflammation through NF-κB activation in a mouse asthma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ting Deng Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 03/2010
22	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2011
11	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2007
9	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2014
5	Disease Progression 12/2022 - 03/2011
5	Carcinoma (Carcinomatosis) 06/2022 - 11/2012
5	Carcinogenesis 10/2021 - 12/2015
4	Esophageal Squamous Cell Carcinoma 01/2022 - 04/2016
4	Asthma (Bronchial Asthma) 01/2020 - 04/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 04/2015
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2021
3	Inflammation (Inflammations) 10/2021 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2014
2	Anemia 04/2022 - 11/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
2	Cachexia 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2021
2	Hypertrophy 01/2020 - 01/2019
2	Respiratory Hypersensitivity 01/2020 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 02/2015
2	Airway Remodeling 01/2020 - 04/2018
2	Hypertension (High Blood Pressure) 07/2019 - 06/2019
2	Type 2 Diabetes Mellitus (MODY) 03/2019 - 06/2018
2	Adenocarcinoma 01/2019 - 08/2015
2	Breast Neoplasms (Breast Cancer) 11/2018 - 09/2014
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 05/2022
1	Leukopenia 04/2022
1	Thrombocytopenia (Thrombopenia) 04/2022
1	Diarrhea 04/2022
1	Neutropenia 04/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Microsatellite Instability 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2021
1	Asthenia 11/2021
1	Alopecia (Baldness) 11/2021
1	Sepsis (Septicemia) 10/2021
1	Necrosis 10/2021
1	Infections 05/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
19	MicroRNAs (MicroRNA)IBA 12/2020 - 03/2011
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
6	Messenger RNA (mRNA)IBA 12/2022 - 08/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
6	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 11/2012
5	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2016
5	Circular RNAIBA 01/2022 - 01/2019
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 01/2015
4	Biological ProductsIBA 12/2022 - 08/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 02/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 11/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 06/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2010
3	Small Interfering RNA (siRNA)IBA 12/2021 - 03/2018
3	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 04/2018
3	Dibutyl Phthalate (Butyl Phthalate)IBA 06/2019 - 01/2018
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 12/2013
3	Leucovorin (Folinic Acid)FDA Link 01/2019 - 02/2013
2	Monoclonal AntibodiesIBA 12/2022 - 01/2022
2	Cetuximab (Erbitux)FDA Link 12/2022 - 01/2015
2	human ERBB2 proteinIBA 11/2021 - 11/2018
2	Blood Glucose (Blood Sugar)IBA 03/2021 - 03/2019
2	BuffersIBA 12/2020 - 12/2020
2	NitrogenIBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2020 - 04/2018
2	Immunoglobulin E (IgE)IBA 01/2020 - 04/2018
2	Urea (Carbamide)FDA LinkGeneric 01/2020 - 01/2019
2	Formaldehyde poisoningIBA 01/2020 - 11/2018
2	Formaldehyde (Formol)FDA Link 01/2020 - 11/2018
2	diisononyl phthalateIBA 01/2020 - 11/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2008
2	CreatinineIBA 01/2020 - 01/2019
2	AntigensIBA 05/2019 - 01/2018
2	EstersIBA 06/2016 - 01/2016
2	Gemcitabine FDA Link 01/2015 - 01/2014
1	Long Noncoding RNAIBA 12/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022
1	PlatinumIBA 04/2022
1	IronIBA 01/2022
1	Growth Factor ReceptorsIBA 01/2022
1	glaucocalyxin AIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	polyphyllin VIIIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	etomoxirIBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 10/2021
1	Karyopherins (Importin)IBA 10/2021
1	trans-crotonin (CTN)IBA 10/2021
1	Dinitrochlorobenzene (DNCB)IBA 06/2021

Therapy/Procedure

17	Therapeutics 04/2022 - 04/2004
12	Drug Therapy (Chemotherapy) 04/2022 - 12/2013
2	Hysterectomy 05/2022 - 04/2015
2	Intravenous Infusions 01/2022 - 01/2019
2	Immunotherapy 01/2022 - 01/2021
1	Minimally Invasive Surgical Procedures 05/2022
1	Reoperation 05/2021